Reaction
Cytomegalovirus Gastrointestinal Infection reporting signals
As of the last recalculation, Cytomegalovirus Gastrointestinal Infection appears in 296 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 631.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 80 | 631.7 | 635.8 |
| Valganciclovir | 93 | 505.3 | 507.8 |
| Valganciclovir Hydrochloride | 93 | 505.3 | 507.8 |
| Ganciclovir | 43 | 345.5 | 346.9 |
| Ganciclovir Sodium | 44 | 343.2 | 344.7 |
| Anti-Thymocyte Globulin (Rabbit) | 18 | 167.0 | 167.4 |
| Basiliximab | 17 | 107.8 | 107.9 |
| Everolimus Tablets | 21 | 94.7 | 94.8 |
| Mycophenolate Mofetil | 113 | 94.0 | 94.1 |
| Mycophenolate Mofetil Hydrochloride | 113 | 93.8 | 93.9 |
| Tacrolimus Ointment 0.1% | 94 | 77.3 | 77.4 |
| Tacrolimus Extended-Release Capsules | 94 | 77.1 | 77.2 |
| Tacrolimus | 102 | 69.3 | 69.4 |
| Sirolimus | 12 | 65.2 | 65.3 |
| Mercaptopurine | 11 | 46.3 | 46.3 |